Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety. Bradhurst P, Hardy TA, Riminton S BMJ Neurol Open. 2026; 8(2):e001611. PMID: 42824951. Abstract CommentRecommendBookmarkWatch
